Moreover, The Cancer Genome Atlas (TCGA) data showed that TRIP13 is frequently mutated or amplified in several kinds of cancer such as lung cancer and esophagus cancer but not in CLL (Supplementary Figure 1). Here, TRIP13 is linked to lung carcinoma.